Action:
Xylometazoline WZF is a drug used to treat nasal congestion caused by swelling of the nasal mucosa due to acute rhinitis (including colds and flu). For inflammation of the paranasal sinuses. For allergic rhinitis (hay fever). For acute otitis media.
The active substance, xylometazoline hydrochloride, has a sympathomimetic effect – it primarily stimulates alpha-adrenergic receptors located, among other things, in the blood vessels of the nasal mucosa. The drug constricts the vessels of the mucous membrane of the nasopharynx, reducing its hyperemia, swelling and exudate. It unblocks the nasal passages and passages leading from the nasal cavity to the paranasal sinuses, reduces nasal discharge and makes breathing through the nose easier.
Ingredients:
Active ingredient: xylomethazole hydrochloride 1 mg/g.
Excipients: disodium phosphate dodecahydrate, sodium dihydrogen phosphate dihydrate, sodium chloride, benzalkonium bromide, purified water.
Dosage:
Adults and children over 12 years of age: 2-3 drops in each nostril every 8-10 hours.
Do not administer more than 3 doses into each nostril per day.
Package:
The package contains 10 ml.
Storage:
Store at room temperature, in a dry place, out of reach of children.
Comments:
Before use, read the instructions, which include indications, contraindications, side effects and dosage information, as well as information on the use of the drug, or consult a doctor or pharmacist, since any medicine used incorrectly poses a threat to your life. or health.
Contraindications:
Hypersensitivity to any of the ingredients of the drug in patients after removal of the pituitary gland or other surgical procedures accompanied by exposure of the dura mater; with atrophic rhinitis.
Be especially careful when using Xylometazoline VZF 0.1%: in patients who, after using other drugs of similar action (sympathomimetics), experienced symptoms such as insomnia, dizziness, tremor, cardiac arrhythmias and increased blood pressure; in patients with cardiovascular diseases (for example, hypertension, angina), diabetes mellitus, closed-angle glaucoma, prostatic hyperplasia, hyperthyroidism. Patients with these diseases should consult a doctor before using the drug. The drug should not be used in patients with chronic or vasomotor rhinitis, as they tend to use it for longer than 5 days. Use of the drug for a longer period than recommended may lead to secondary vasodilation and, as a consequence, to secondary drug-induced rhinitis.
Use special caution in certain groups using the drug.
Use of xylometazoline WZF 0.1% in children
Xylometazoline WZF 0.1% can be used in children over 12 years of age. In young children, xylometazoline WZF 0.1% should be used.
Pregnancy
Before taking any medicine, ask your doctor for advice.
Xylometazoline WZF 0.1% should not be used during pregnancy.
Breast-feeding
Before taking any medicine, ask your doctor for advice.
Driving and using cars
The drug does not affect the ability to drive a car or operate machinery when used in recommended doses and for a short period of time.
In case of long-term use of the drug or use in high doses, side effects on the circulatory system and central nervous system may occur, which may adversely affect the performance of these activities.
Important information about some of the ingredients of Xylometazoline WZF 0.1%.
Due to the content of benzalkonium chloride, the drug may cause irritation of the nasal mucosa.
Taking other medications
Xylometazoline WZF 0.1% should not be used during treatment with tricyclic antidepressants and MAO inhibitors (medicines used particularly for depression) as interactions have been reported.
Avoid simultaneous use of the drug with other drugs of similar action (sympathomimetics), such as ephedrine, pseudoephedrine.
Possible side effects
Like all medicines, Xylometazoline WZF 0.1% can cause side effects, although not everyone gets them.
After using the drug, local side effects may occur: irritation of the nasal mucosa, dryness of the nasal mucosa, burning sensation in the nose and throat, sneezing. Symptoms of systemic exposure are very rare: nausea, headache, weakness, fatigue, drowsiness, visual disturbances, allergic reactions (shortness of breath, angioedema) and palpitations, increased heart rate, increased blood pressure (especially in persons with cardiovascular diseases).
